NCT04400760View on ClinicalTrials.gov

The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Platelet Dysfunction
Interventions
DRUG

DAPA Tx

The intervention, dapagliflozin will be administered 10mg per oral daily for two weeks.

Trial Locations (1)

00000

Eric Williams Medical Sciences Complex, Port of Spain

All Listed Sponsors
lead

The University of The West Indies

OTHER

NCT04400760 - The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts. | Biotech Hunter | Biotech Hunter